Method of treating cancer comprising a VEGF-B antagonist
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 2, 2014
Grant Date -
Oct 23, 2008
app pub date -
Aug 2, 2005
filing date -
Aug 2, 2004
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates generally to the field of cancer therapy and prophylaxis. More particularly, the present invention provides growth factor antagonists which inhibit the growth of cancers including tumors and pre-cancerous tissue. Even more particularly, the present invention is directed to antagonists of vascular endothelial growth factor-B and their use to inhibit the growth of cancer including tumor tissue and pre-cancerous tissue.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully